- Home
- GRX vs SCPH Comparison
GRX vs SCPH Comparison
Compare GRX & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRX
- SCPH
- Stock Information
- Founded
- GRX 2007
- SCPH 2013
- Country
- GRX United States
- SCPH United States
- Employees
- GRX N/A
- SCPH N/A
- Industry
- GRX Finance/Investors Services
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- GRX Finance
- SCPH Health Care
- Exchange
- GRX Nasdaq
- SCPH Nasdaq
- Market Cap
- GRX 156.7M
- SCPH 173.6M
- IPO Year
- GRX N/A
- SCPH 2017
- Fundamental
- Price
- GRX $10.01
- SCPH $2.78
- Analyst Decision
- GRX
- SCPH Strong Buy
- Analyst Count
- GRX 0
- SCPH 3
- Target Price
- GRX N/A
- SCPH $14.00
- AVG Volume (30 Days)
- GRX 39.7K
- SCPH 637.0K
- Earning Date
- GRX 01-01-0001
- SCPH 03-19-2025
- Dividend Yield
- GRX 5.98%
- SCPH N/A
- EPS Growth
- GRX N/A
- SCPH N/A
- EPS
- GRX 0.26
- SCPH N/A
- Revenue
- GRX N/A
- SCPH $36,332,000.00
- Revenue This Year
- GRX N/A
- SCPH $134.20
- Revenue Next Year
- GRX N/A
- SCPH $99.40
- P/E Ratio
- GRX $38.50
- SCPH N/A
- Revenue Growth
- GRX N/A
- SCPH 167.28
- 52 Week Low
- GRX $7.73
- SCPH $2.72
- 52 Week High
- GRX $10.40
- SCPH $5.65
- Technical
- Relative Strength Index (RSI)
- GRX 50.63
- SCPH 34.45
- Support Level
- GRX $9.91
- SCPH $2.87
- Resistance Level
- GRX $10.02
- SCPH $3.08
- Average True Range (ATR)
- GRX 0.09
- SCPH 0.18
- MACD
- GRX 0.01
- SCPH -0.00
- Stochastic Oscillator
- GRX 57.14
- SCPH 11.70
About GRX The Gabelli Healthcare & Wellness Trust of Beneficial Interest
Gabelli Healthcare & WellnessRx Trust operates as a diversified closed-end management investment company. The investment objective of the fund is the long-term growth of capital. The fund invests at least its assets in equity securities and income-producing securities of domestic and foreign companies in the healthcare and wellness industries. It invests in various sectors, of which Health Care Providers & Services, Food, Health Care Equipment and Supplies, and Pharmaceuticals account for the majority of the weightage.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.